Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials
Atti V, Gwon Y, Narayanan MA, Garcia S, Sandoval Y, Brilakis ES, Basir MB, Turagam MK, Khandelwal A, Mena-Hurtado C, Mamas MA, Abbott JD, Bhatt DL, Velagapudi P. Multivessel Versus Culprit-Only Revascularization in STEMI and Multivessel Coronary Artery Disease Meta-Analysis of Randomized Trials. JACC Cardiovascular Interventions 2020, 13: 1571-1582. PMID: 32646699, DOI: 10.1016/j.jcin.2020.04.055.Peer-Reviewed Original ResearchConceptsMultivessel percutaneous coronary interventionST-segment elevation myocardial infarctionPercutaneous coronary interventionElevation myocardial infarctionMultivessel coronary artery diseaseCulprit vesselCoronary artery diseaseCause mortalityMyocardial infarctionArtery diseaseControlled TrialsRisk ratioLower riskUnderwent multivessel PCIVersus Culprit-Only RevascularizationCulprit-only revascularizationMultivessel PCI strategyPrimary efficacy outcomeCochrane Central RegisterContrast-induced nephropathyConfidence intervalsRandom-effects modelWeb of ScienceMajor bleedingCardiovascular mortality